GLP-1 receptor agonists have a very good profile in terms of reducing excess weight and inflammation, both of which have established links to cancer," Jiang Bian, PhD, MS, FACMI, associate dean for data science at Indiana University School of Medicine and chief data scientist for IU Health and Regenstrief Institute, told Healio
Our article on how to safely transition from medication to lifestyle-only weight loss explores this in detail
Furthermore, the change in the HbA1c value from baseline did not affect the result, suggesting that once-weekly exenatide reduced albuminuria independent of the glucose-lowering effect (Van Der Aart-Van Der Beek et al., 2020)
During this window, the drug molecules are finding and binding to GLP-1 receptors scattered throughout your body